ARTICLE | Distillery Therapeutics
Neurology
January 11, 2017 12:51 AM UTC
Cell culture studies suggest inhibiting the bromodomains of CREBBP and EP300 could help treat HD. In a human osteosarcoma cell line expressing a disease-associated mutant HTT, three tool compounds tha...
BCIQ Company Profiles